Track 1: Cancer Stem Cell
Cancer Stem Cell (CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.
• Embryonic Stem Cell
• Epigenetics
• Stem Cell Therapy
• Stem Cell Transplantation
Track 2: Coronavirus (COVID-19) and cancer treatment
The coronavirus causes a sickness called COVID-19 which can affect mainly the lungs and airways. For majority of the people, the virus will not cause any serious problem. But for the people with cancer, the virus can have serious complications. This is happens because cancer and treatment can deteriorate your immune system.
Treatment risks:
• How cancer treatments affect your immune system - you’re more at risk of becoming extremely ill from COVID 19 if your immune system is weak after treatment
• Exposure to the virus during hospital visits – your crew will look at how you have your treatment to lessen your hospital visits
Track 3: Oncology Research Categories
Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancer disease, kind of consideration or drug, condition or encompassing.
• Medical oncology
• Radiation Oncology
• Surgical Oncology
• Clinical Oncology
• Paediatric Oncology
Track 4: Bio-markers of Cancer Stem Cells
Liver cancer is the most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.
• RAPD
• Transciptomic Biomarkers
• Proteomic Biomarkers
• RFLP
Track 5: Cancer Stem Cell Treatments
Cancer treatments contrary to tumour, chemo-and radiotherapy, have numerous restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs.
• Gene Treatment
• Epigenic Alternatives
• Radiation Treatments
Track 6: Nanotechnology in Cancer
Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the subdivision in nanotechnology that uses Nano-science and Nano vectors to stop or cure cancer cells and their growth.
• Cancer Diagnosis
• Cancer Treatment
• Immunotherapy
• Nanotechnology in Cancer Cure
Track 7: Cancer Causes
There can be more than one reason for cancer cells formation and growth. Numerous powers can effect quality changes, like smoking, infections, radiation, Cancer causing synthetic compounds (cancer-causing agents), hormones, heftiness, endless aggravation and an absence of activity.
• Hereditary Malignancies
• Radiation effect
• Lifestyle effects
Track 8: Cancer prevention
Cancer Prevention comprises steps that are taken to bring down the danger of getting the Cancer disease. This may include keeping up a firm way of life, to recognize disease causing substances and taking prescriptions or immunizations that can keep cancer from formation.
• Proper and Healthy Diet
• Medication
• Change in Lifestyle
Track 9: Bioinformatics and Systems Biology
Bioinformatics and System Biology utilize PC techniques to investigate the natural information. As opposed to the past attention on single qualities or proteins, frameworks science is a field of research which focuses on understanding whole natural frameworks, for example: protein buildings, metabolic pathways, or quality administrative systems.
• Molecules and Cells
• Genes, Systems, and Evolution
• Statistics in Biology
• Applied Genomics
• Programming for Biologists
• Biological Databases and Data mining
• Bioinformatics and Evolutionary Genomics
Track 10: Gene therapy
Gene Therapy is an exploratory strategy that utilizes qualities to treat or anticipate ailment. Later on, this strategy may enable specialists to treat confusion by embedding a quality into a patient's cells as opposed to utilizing medications or medical procedure. In spite of the fact that gene therapy is a promising treatment alternative for various ailments (counting acquired disarranges, a few sorts of malignancy, and certain viral contaminations), the system stays hazardous is still under examination to ensure that it will be protected and successful. Gene Therapy is as of now being tried just for maladies that have no different fixes
• Macular Degeneration
• Utero CRISPR
• Metabolic liver disease
• CRISPR–Cas9 genome-wide nuclease
• Streptococcus pyogenic
• Immunoglobulin therapy for Kawasaki disease
Track 11: Advanced in Tissue Regeneration
Tissue Engineering is a logical field and depicted as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building deals about the investigation of mixing of cells, structuring, materials and methodologies, biochemical segments to upgrade characteristic tissues. It includes the utilization of Scaffolds to shape practical tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques alongside some hemispherical elements. It is recognized with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish all the qualities of an organ.
• Tissue Engineering
• Regenerative Medicine
• Bio Materials
• Scaffolds
• Tissue Regeneration
Track 12: Stem Cell and Tissue Homeostasis
Tissue homeostasis depends upon the exact direction of substantial foundational microorganism movement. The administrative systems involved with these reactions are presently being separated in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.
• Stem cells and their niches
• Hematopoietic stem cells
• Stem cells and the origin of intestinal cancer
Track 13: Stem Cell Therapy
Essential microorganisms are the body's rough materials cells from which each other cell with particular boundaries are created. New stem cells either end up being new undifferentiated cells with a more specific limit for instance: platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the featured ability to make new cell types.
• Acute Lymphoblastic Leukaemia
• Acute Megakaryocytic Leukaemia
• Acute Myelomonocytic Leukaemia
• Lymphoma Cancer
• Immune Cell Therapy
• Allogeneic transplantation.
• Advances in Bone Marrow Stem Cell
Track 14: Epidermal Stem Cells
The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration. Microorganisms (Stem cells) dwelling in the epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fixation of the epidermis after wounds.
• Stem cells with in adult skin epithelium
• Signalling and stem cell fate specification in the skin
• Bone Morphogenetic Protein Signalling
• Notch Signalling
Track 15: Ethics considerations in stem cell therapy
Stem Cell Research offers incredible guarantee for understanding fundamental elements of human advancement and separation, additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell investigates about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches
• Multi-potent Stem Cells
• Embryonic Stem Cell Research
• Somatic Cell Nuclear Transfer
• Induced Pluripotent Stem Cells Stem Cell Clinical Trials
Track 16: Advances in developmental biology and stem cells
Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science has its heritage in formative science. Formative science keeps on moving on, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reaffirmed as a critical research program.
• Tissue compartmentalisation
• Oncogenic perturbation of stem cell behaviour
• Compartmentalisation and heterogeneity beyond the epidermis
Track 17: Stem Cell Renewal
Self-restoration is the cycle by which stem cells partition to make more stem cells, propagating the stem cell pool all through life. Self-reestablishment is division with upkeep of the undifferentiated state. This requires cell cycle control and regularly upkeep of multipotency or pluripotency, contingent upon the stem cell. Self-restoration programs include networks that balance proto-oncogenes (advancing self-reestablishment), door keeping tumor silencers (restricting self-recharging), and care-taking tumor silencers (keeping up genomic uprightness). These phone characteristic instruments are managed by cell-extraneous signs from the specialty, the microenvironment that keeps up stem cells and controls their capacity in tissues. In light of changing tissue requests, stem cells go through changes in cell cycle status and formative potential after some time, requiring distinctive self-reestablishment programs at various phases of life. Decreased stem cell capacity and tissue regenerative limit during maturing are brought about by changes in self-recharging programs that enlarge tumor concealment. Malignant growth emerges from changes that improperly enact self-restoration programs.
• Regenerative medicine and iPS
• Somatic self-renewal and aging
• Somatic stem and progenitor cell aging
Track 18: Recent advances in Stem Cell
All the immature microorganisms possess an amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual is alive, thus offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses. Until today, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" micro-organisms. On-going achievement makes it conceivable to change over or "re-invent" specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.
• Embryonic stem cells
• Somatic cell nuclear transfer (SCNT)
• Induced pluripotent stem cell (iPSC)
• Stimulus-triggered acquisition of pluripotency (STAP)
• Adult Stem Cells
• Adult Neural Stem Cells
Track 19: Stem Cell Aging
The stem cell hypothesis of maturing proposes that the maturing cycle is the consequence of the failure of different kinds of stem cells to keep on renewing the tissues of a creature with utilitarian separated cells fit for keeping up that tissue's (or organ's) unique capacity. Harm and mistake collection in hereditary material is consistently an issue for systems paying little mind to the age. The quantity of stem cells in youngsters is a lot of higher than more seasoned individuals and in this way makes a superior and more proficient substitution component in the youthful as opposed to the old. As it were, maturing doesn't involve the expansion in harm, however a matter of inability to supplant it because of a diminished number of stem cells. Stem cells decline in number and will in general lose the capacity to separate into descendants or lymphoid genealogies and myeloid ancestries.
• Theories of aging
• Theories of biological aging
• Proximate theories of biological aging
• Alzheimer‘s disease
• Cardiovascular diseases
Track 20: Umbilical Cord Stem Cells
Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.
• Corneal disease
• Umbilical cord blood transplant.
Track 21: Stem Cell Biology and advances
Most of the structural microorganisms have the astonishing potential to form into a wide range of cell types, basically unlimited to renew different cells until the individual is alive, offering any expectation of relieving Alzheimer's disease , treating kidney, liver and lung diseases . Until today, researchers principally worked with two types of undistinguishable organisms from creatures and people that are embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cell with various improvements. The audit will quickly talk about the on-going developments here.
• Stem cells in endocrinology
• Liver stem cells and regeneration
• Early embryonic development
• Neural stem cells and regeneration
• Blood stem cells and regeneration
• Muscle (cardiac and skeletal) stem cells and regeneration
• Totipotency, pluripotency and multipotency
Track 22: 3D Bio printing & Bio fabrication
Bio fabrication is alluded to the generation of fake tissues or organs to address wellbeing challenges in medication. It frequently utilizes the rule of 3D Bio printing to shape cells, gels and strands into an organ.
• Bioprinting using microfluidics
• Bio inks
• Engineered Tissue
• 3D printing technologies
• Innovative development in 3D-bioprinting
• Intelligent bio materials
Track 23: Clinical research and trials in stem cells and cancer
Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells
• Cellular therapy
• Tissue regeneration
• Drug discovery
• Stem Cell Transplantation
Track 24: Cancer Treatment
The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.
• Chemotherapy
• Immunotherapy
• Hormonal Treatment
• Use of Inhibitors
• Photodynamic Treatment
Track 25: Cancer Stages
Specialists join the T, N, M results and different elements explicit to the disease to decide the phase of malignant growth for every individual. Most kinds of disease have four phases: stages I (1) to IV (4). A few malignancies likewise have a phase 0 (zero).
Stage 0. This stage depicts malignancy in situ, which signifies "set up." Stage 0 tumors are as yet situated in the spot they began and have not spread to close by tissues. This phase of disease is frequently profoundly reparable, generally by eliminating the whole tumor with medical procedure.
Stage I. This stage is typically a little malignant growth or tumor that has not developed profoundly into close by tissues. It likewise has not spread to the lymph hubs or different pieces of the body. It is frequently called beginning phase disease.
Stage II and Stage III. As a rule, these 2 phases show bigger malignancies or tumors that have developed all the more profoundly into close by tissue. They may have likewise spread to lymph hubs however not to different pieces of the body.
Stage IV. This stage implies that the disease has spread to different organs or parts of the body. It might likewise be called progressed or metastatic malignant growth.
• TNM framework organizing
• Post Therapy
• Recurrence
• Autopsy
Track 26: Types of Cancer
Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This includes a large number of the most widely recognized malignancies and incorporate almost each one of those in the breast, prostate, lung, pancreas and colon.
• Bladder Cancer
• Breast Cancer
• Colon and Rectal Cancer
• Endometrial Cancer
• Kidney Cancer
• Leukaemia
• Liver Lung Cancer
• Melanoma
• Non-Hodgkin Lymphoma
• Pancreatic Cancer
• Prostate Cancer
• Thyroid Cancer
Track 27: Immunology
Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseases,, hypersensitivities immune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.
• Pluripotent Stem Cells
• Haemopoetic Stem Cell
• Stem Cell Niche
• Mesenchymal Stem Cell
• Molecular Signalling
Track 28: Stem cells
Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.
• Medical oncology
• Radiation Oncology
• Surgical Oncology
• Clinical Oncology
• Paediatric Oncology
Track 29: Oncology Research
Oncology Research and Treatment offers an interdisciplinary discussion for malignancy examination and treatment. Companion evaluated unique and audit articles spread a wide scope of perspectives in clinical hematology and oncology, careful, neurosurgical, gynecological, pediatric and urological oncology, oral and maxillofacial medical procedure, dermatological oncology, diagnostics, radiation oncology, mental consideration, pathology, clinical-translational oncology, biometry, and oncological recovery. Consistent clinical training and clinical news structure a further core interest. Reduced and momentum, Oncology Research and Treatment keeps the two clinicians and scientists exceptional. Oncology Research and Treatment is routed to clinicians and experts working and investigating in the field of hematology and oncology.
• Immuno Oncology
• Nursing Oncology
• Cancer Science
• Oncogenes
• Abnormal Cell growth
• Tumours
The global stem cells market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.
Stem Cell Therapy Market revenue will reach $15 billion by 2025. Oncology segment held over 39% revenue in 2021. The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024, and is also predicted to reach USD 214.5 million by the end of 2024.
Market Analysis Report:
Cancer is a disease categorized by the uncontrolled growth and spread of abnormal cells. If the growth of these cells is not controlled, it can result in death. Cancer has higher death rate than AIDS, tuberculosis and malaria. Based upon the income when countries are grouped, cancer is the second leading cause of death in high-income countries and the third leading cause of death in low- and middle-income countries.
Cancer Diagnostic Market:
By Technology:
A. Platform Based:
In situ Hybridization
Flow Cytometry
Next-generation Sequencing
Microarrays
Others
B. Instrument Based:
Biopsy
Mammography
PET
Ultrasound
MRI
CT
List of the global cancer diagnostics system market are:
Sanofi (France)
Novartis (Germany)
Pfizer Inc. (U.S.)
Eli Lilly & Company (U.S.)
ImClone Systems Inc. (U.S.)
GlaxoSmithKline (U.K)
AstraZeneca (U.K)
Schering-Plough (U.S.)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb
Teva Pharmaceuticals Industries (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)
Merck & Co., Inc. (U.S.)
Chemo Espana SL (Spain)
CELGENE CORPORATION (U.S.)
Amgen Inc (U.S.)
Bayer AG (Germany)
Takeda Pharmaceutical Company Limited (Japan)
List of Associations Worldwide:
American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Paediatric Haematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre
List of Medical Universities worldwide:
Harvard University
University of Minnesota
Mayo Medical School
Pittsburgh School of Medicine
Yale University
University of Cambridge
University of Oxford Stanford University
Yale University
Emory University
John Hopkins University
Kings College London
Feinberg School of Medicine
University of Wisconsin
UNC School of Medicine
Karolinska University
List of medical universities in France:
Université de Paris
Sorbonne Universite
University of Aix-Marseille
Universite de Bordeaux
University of Montpellier
Universite de Lorraine
Cancer related companies:
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
Pfizer
F. Hoffmann-La Roche Ltd
Celgene Corp
Novartis AG
Bristol-Myers Squibb Co
Samsung Medical Centre
